Increased Virulence From COVID-19 Variants Is Similar Across Age Groups
Researchers conducted a study to determine whether increases in virulence and disease severity associated with SARS-CoV-2 variants of concern are similar across age groups.
All articles by Bradley van Paridon
Favorable Benefit to Risk Ratio Noted for Iberdomide in Patients With Systemic Lupus Erythematosus
Researchers assessed the safety, pharmacokinetics, pharmacodynamics, and efficacy of iberdomide in patients with systemic lupus erythematosus.
Prevalence of COVID-19-Related Multisystem Inflammatory Syndrome Hospitalizations in Children
Researchers conducted a study to compare hospitalizations due to COVID-19 infection plus multisystem inflammatory syndrome with those due to influenza and respiratory syncytial virus infection among children between 5 and 11 years.
Systemic Lupus Erythematosus: Certain Factors Drive Severe COVID-19 Outcomes
The aim of the study was to determine the characteristics associated with severe COVID-19 outcomes among patients with systemic lupus erythematosus
Gout Found to Be a Risk Factor for COVID-19 Diagnosis and Death
Researchers assessed the effect of gout on risk for COVID-19 diagnosis and death, using data from the UK Biobank.
Accuracy of Self-Reported Taste Impairment in Patients With “Long-Haul COVID”
Investigators conducted a study to determine the accuracy of self-reported taste impairment via psychophysical evaluation in patients with long-haul COVID-19 infection.
Patients With vs Without Rheumatoid Arthritis Have Higher Prevalence of Multimorbidity
Researchers assessed the multimorbidity burden in patients with rheumatoid arthritis to determine the multimorbidity definition for research and clinical practice.
Reliability of Ultrasound and Elastography in the Assessment of Skin Involvement in SSc
Authors of a systematic review evaluated available literature assessing the role of ultrasound and elastography in skin involvement in systemic sclerosis.
Sarilumab May Not Improve Outcomes in Patients With Moderate to Severe COVID-19 Pneumonia
Researchers evaluated the effect of sarilumab treatment on the outcomes of patients hospitalized with moderate to severe COVID-19 pneumonia.
Novel Patient-Reported Outcome Tool Assesses Fatigue in Patients With Systemic Lupus Erythematosus
Researchers studied the implementation of a new patient-reported outcome instrument to measure and manage fatigue in patients with systemic lupus erythematosus.
- Loading...
Loading...
Next post in Systemic Lupus Erythematosus
Loading... 
Loading...